Goudie L: Difference between revisions
From Bioblast
(Created page with "{{Person |lastname=Goudie |firstname=Luke |title= |institution=Department of Biochemistry & Molecular Biology Faculty of Kinesiology, Medicine University of Calgary |address=...") |
No edit summary |
||
Line 14: | Line 14: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
==Participated at== | |||
::::* [[MiPNet22.01_IOC122_Schroecken_AT | IOC122 Schroecken AT]] |
Revision as of 12:01, 21 June 2017
Name | Goudie Luke, |
---|---|
Institution | Department of Biochemistry & Molecular Biology
Faculty of Kinesiology, Medicine University of Calgary |
Address | 2500 University Drive NW, KIN 306, |
City | Calgary |
State/Province | |
Country | Canada |
[email protected] | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Goudie 2022 Sci Rep | 2022 | Goudie L, Mancini NL, Shutt TE, Holloway GP, Mu C, Wang A, McKay DM, Shearer J (2022) Impact of experimental colitis on mitochondrial bioenergetics in intestinal epithelial cells. https://doi.org/10.1038/s41598-022-11123-w |
Abstracts
Published | Reference | |
---|---|---|
Goudie 2017 Abstract IOC122 | 2017 | Inhibition of mitochondrial fission as a novel treatment for IBD. |